MaxCyte
partnerships near and long term revenue potential with strong upside in commercial opportunity | MaxCyte
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
13 of 25
Similar slides by MaxCyte
See diffirences between slides (animation)
Investor Presentation
January 2024
partnerships near and long term revenue potential with strong upside in commercial opportunity | MaxCyte
Investor Presentation
October 2023
partnerships near and long term revenue potential with strong upside in commercial opportunity | MaxCyte
Investor Presentation
August 2023
partnerships near and long term revenue potential with strong upside in commercial opportunity | MaxCyte
Related slides by other companies
Poseida Therapeutics
IPO
July 2020
program has broad potential in multiple indications | Poseida Therapeutics
Kymera
Investor Presentation
November 2023
clinical and near term clinical pipeline of novel protein degraders | Kymera
Kymera
Investor Presentation
December 2023
clinical and near term clinical pipeline of novel protein degraders | Kymera
Ginkgo
Investor Conference
June 2021
spending alone accounts for nearly in untapped demand this market represents over potential new cell programs | Ginkgo
Other recent decks by MaxCyte
See all presentations (8 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights